hematologic side effects
methemoglobinemia
aplastic anemia
leukopenia
agranulocytosis
eosinophilia
macrocytic anemia
heinz bodies
dapsone
dose-related hemolytic anemia
doses
mg/day
patients with glucose
phosphate dehydrogenase
g
pd
deficiency
leukopenia
megaloblastic pancytopenia
hemolysis
case of pure red cell aplasia
addition
case of exanthema with desquamation of the trunk
extremities
agranulocytosis
first few months of therapy
case report
filgrastim
g-csf
agranulocytosis
dapsone
methemoglobinemia
patients
underlying
underlying respiratory insufficiency
anemia
cardiovascular disease
patients with methemoglobinemia
normal oxygen saturation by pulse oximetry
arterial blood gas
abg
diagnosis
cyanosis
dyspnea
patients
underlying
underlying respiratory insufficiency
elevated methemoglobin level from abg sampling
reversal of brown blood
addition of cyanide
methemoglobin levels
peripheral cyanosis
concentrations
symptoms of weakness
headache
dyspnea
fatality
recent data
vitamin e
dapsone-induced hemolytic anemia
methemoglobinemia
more studies
aplastic anemia
dapsone
onset of aplastic anemia
weeks
following initiation of therapy
year-old male with granuloma annulare
pure red cell aplasia
prca
dapsone therapy
given dapsone mg per day
weeks after the start of this therapy
patient
asthenia
diagnosis of prca
hematological counts
dapsone
patient
received blood transfusions
condition
hematological counts
normal levels
peripheral neuropathy
hands
resulting in thenar
hypothenar
interosseous muscle atrophy
rare cases of pure sensory loss
dapsone-induced peripheral neuropathy
treatment of leprosy
peripheral neuropathy
leprosy
reactional state
isolated case of optic atrophy
patient
receiving dapsone mg/day for days
nervous system
side effects
peripheral neuropathy
motor deficits
cases
sensory loss
peripheral neuropathy
discontinuation of dapsone
dizziness
vertigo
vision
headache
case of paresthesias
gastrointestinal side effects
mild nausea
vomiting
abdominal pains
hepatic side effects
elevations in liver function tests
part of the dapsone syndrome
rare cases of hepatitis
cholestatic jaundice
hyperbilirubinemia
hyperbilirubinemia
patients with glucose
phosphate dehydrogenase
g
pd
deficiency
respiratory side effects
cases of pulmonary eosinophilia
patient
pyrimethamine
dapsone
other patient
dapsone
patients
drug withdrawal
rare cases of dapsone-induced lupus erythematosus
exacerbations
existing lupus erythematosus
psychiatric side effects
depression
psychosis
hypomania
paucibacillary leprosy
renal hypersensitivity vasculitis
dapsone therapy
prescribed dapsone mg per day
rifampicin mg per month
days of treatment
treatment
low fever
headache
dizziness
weakness
presentation
addition
symptoms
patient
fever
respiratory discomfort
dry cough
jaundice
arterial hypotension
edema
pruritus of the face
vesicopustular skin rash
skin rash
exfoliative erythroderma
purpura of the lower extremities
severe acute failure
oliguria
days after admission
day
kidney
immunohistochemical studies
interstitial perivascular lymphocytic infiltrate
media of arched
interlobular arteries
t cells
patient
renal function
dermatological condition
months after admission
hypersensitivity side effects
hiv-infected patients
rash
stevens-johnson syndrome
toxic erythema
erythema multiforme
toxic epidermal necrolysis
morbilliform
scariatiniform reactions
few patients
dapsone
other sulfone agents
rare cases of dapsone-induced lupus erythematosus
exacerbations
existing lupus erythematosus
sulfone syndrome
case of renal hypersensitivity vasculitis
renal side effects
nephritic syndrome
renal papillary necrosis
other side effects
dapsone syndrome
dapsone syndrome
viral illness-like symptoms
fever
chills
myalgias
arthralgias
exanthema
lymphadenopathy
edema
lymphocytosis
elevated liver function tests
methemoglobinemia
anemia
signs
symptoms
patients
dapsone syndrome
first weeks of therapy
dapsone syndrome
infectious mononucleosis
leprosy
reactional states
result of effective treatment for leprosy
types
reversal reactions
type
erythema nodosum leprosum
enl
type
reversal reactions
tuberculoid leprosy patients
initiation of chemotherapy
fever
swelling
existing skin
nerve lesions
acute neuritis
enl
lepromatous patients
treated patients within the first year
small number of borderline patients
manifestations
fever
tender
erythematous skin nodules
malaise
neuritis
orchitis
albuminuria
joint swelling
iritis
epistaxis
depression
addition
skin lesions
histologically
vasculitis with an intense polymorphonuclear infiltrate
antileprosy treatment
patients with severe reactions
hospitalization
therapeutic management for reversal reactions
administration of analgesics
corticosteroids
surgical decompression of swollen nerve trunks
analgesics
corticosteroids
other agents
enl reactions
guidance
management of reactional states
gillis w.
long hansen
disease center in carville
louisiana
tel
leg
stomach pains
bluish fingernails
lips
skin
difficult breathing
fever
loss of appetite
pale skin
skin rash
unusual tiredness
weakness
itching
dryness
redness
scaling
peeling of the skin
loss of hair
mood
other mental changes
numbness
tingling
pain
burning
weakness in hands
feet
sore throat
unusual bleeding
bruising
yellow eyes
skin
headache
loss of appetite
nausea or vomiting
nervousness
trouble in sleeping